Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-024770
Filing Date
2010-03-15
Accepted
2010-03-15 17:15:06
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w77690e10vk.htm 10-K 1164232
2 EX-10.37 w77690exv10w37.htm EX-10.37 365165
3 EX-23.1 w77690exv23w1.htm EX-23.1 1343
4 EX-31.1 w77690exv31w1.htm EX-31.1 8199
5 EX-31.2 w77690exv31w2.htm EX-31.2 8509
6 EX-32.1 w77690exv32w1.htm EX-32.1 4077
7 EX-32.2 w77690exv32w2.htm EX-32.2 4067
8 GRAPHIC w77690w7769001.gif GRAPHIC 11642
  Complete submission text file 0000950123-10-024770.txt   1573230
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 10682513
SIC: 2834 Pharmaceutical Preparations